TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
6 hedge funds and large institutions have $1.69M invested in TIANYIN PHARMACEUTICAL in 2014 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
33% less funds holding
Funds holding: 9 → 6 (-3)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
44% less capital invested
Capital invested by funds: $3.03M → $1.69M (-$1.34M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$47.4K |
| 2 |
RIM
Regent Investment Management
Louisville,
Kentucky
|
+$515 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $1.15M | -$549K | -694,231 | -30% |
|
|
2
Renaissance Technologies
New York
| $490K | +$47.4K | +60,000 | +10% |
|
|
RIM
3
Regent Investment Management
Louisville,
Kentucky
| $18K | +$515 | +652 | +3% |
|
|
SIM
4
Spark Investment Management
New York
| $16K | -$2.85K | -3,600 | -14% |
|
5
Citadel Advisors
Miami,
Florida
| $13K | -$16.4K | -20,684 | -53% |
|
|
BWFA
6
Baltimore-Washington Financial Advisors
Columbia,
Maryland
| $4K | – | – | – |
|
|
VKH
7
Virtu KCG Holdings
New York
| – | -$39K | -40,039 | Closed |
|
|
RCM
8
Rotella Capital Management
Bellevue,
Washington
| – | -$30K | -30,305 | Closed |
|
|
CS
9
Credit Suisse
Zurich,
Switzerland
| – | -$15K | -15,343 | Closed |
|
TPI Hedge Fund Activity: Q2 2014 in Review
6 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q2 2014, worth a combined $1.69M — down 44% from $3.03M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TPI and 0 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $47.4K. The largest seller was Pope Asset Management, cutting an estimated $549K.
- 6 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q2 2014, down from 9 in Q1 2014.
- Funds reported $1.69M of TIANYIN PHARMACEUTICAL stock for Q2 2014, down 44% quarter-over-quarter.
- 0 funds opened new TIANYIN PHARMACEUTICAL positions in Q2 2014 and 3 closed out, a net change of -3 holders.
- The largest TIANYIN PHARMACEUTICAL buyer in Q2 2014 was Renaissance Technologies, an estimated $47.4K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q2 2014 was Pope Asset Management, an estimated $549K sold.
Based on aggregated 13F filings for Q2 2014.